304 related articles for article (PubMed ID: 34718238)
21. Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
Li D; Qian J; Li J; Wang J; Liu W; Li Q; Wu D
J Toxicol Sci; 2022; 47(5):169-181. PubMed ID: 35527005
[TBL] [Abstract][Full Text] [Related]
22. Protective effect of dexmedetomidine on neuronal hypoxic injury through inhibition of miR-134.
Li YJ; Zhang DZ; Xi Y; Wu CA
Hum Exp Toxicol; 2021 Dec; 40(12):2145-2155. PubMed ID: 34121490
[TBL] [Abstract][Full Text] [Related]
23. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress.
Li W; Li W; Leng Y; Xiong Y; Xia Z
DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190
[TBL] [Abstract][Full Text] [Related]
24. Inhibiting (pro)renin receptor-mediated p38 MAPK signaling decreases hypoxia/reoxygenation-induced apoptosis in H9c2 cells.
Liu Y; Zhang S; Su D; Liu J; Cheng Y; Zou L; Li W; Jiang Y
Mol Cell Biochem; 2015 May; 403(1-2):267-76. PubMed ID: 25711402
[TBL] [Abstract][Full Text] [Related]
25. Hypoxic preconditioning protects microvascular endothelial cells against hypoxia/reoxygenation injury by attenuating endoplasmic reticulum stress.
Wu XD; Zhang ZY; Sun S; Li YZ; Wang XR; Zhu XQ; Li WH; Liu XH
Apoptosis; 2013 Jan; 18(1):85-98. PubMed ID: 23108759
[TBL] [Abstract][Full Text] [Related]
26. Involvement of miR-665 in protection effect of dexmedetomidine against Oxidative Stress Injury in myocardial cells via CB2 and CK1.
Yu J; Yang W; Wang W; Wang Z; Pu Y; Chen H; Wang F; Qian J
Biomed Pharmacother; 2019 Jul; 115():108894. PubMed ID: 31026731
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of miR-148b ameliorates myocardial ischemia/reperfusion injury via regulation of Wnt/β-catenin signaling pathway.
Yang M; Kong DY; Chen JC
J Cell Physiol; 2019 Aug; 234(10):17757-17766. PubMed ID: 30820984
[TBL] [Abstract][Full Text] [Related]
28. Rutin alleviates hypoxia/reoxygenation-induced injury in myocardial cells by up-regulating SIRT1 expression.
Yang H; Wang C; Zhang L; Lv J; Ni H
Chem Biol Interact; 2019 Jan; 297():44-49. PubMed ID: 30365940
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-7b attenuates ischemia/reperfusion-induced H9C2 cardiomyocyte apoptosis via the hypoxia inducible factor-1/p-p38 pathway.
Sheng Z; Lu W; Zuo Z; Wang D; Zuo P; Yao Y; Ma G
J Cell Biochem; 2019 Jun; 120(6):9947-9955. PubMed ID: 30548297
[TBL] [Abstract][Full Text] [Related]
30. Dexmedetomidine inhibits pyroptosis by down-regulating miR-29b in myocardial ischemia reperfusion injury in rats.
Zhong Y; Li YP; Yin YQ; Hu BL; Gao H
Int Immunopharmacol; 2020 Sep; 86():106768. PubMed ID: 32679539
[TBL] [Abstract][Full Text] [Related]
31. Dexmedetomidine alleviates myocardial ischemia-reperfusion injury by down-regulating miR-34b-3p to activate the Jagged1/Notch signaling pathway.
Guo P; Yi H; Han M; Liu X; Chen K; Qing J; Yang F
Int Immunopharmacol; 2023 Mar; 116():109766. PubMed ID: 36764271
[TBL] [Abstract][Full Text] [Related]
32. Dexmedetomidine attenuates ischemia and reperfusion-induced cardiomyocyte injury through p53 and forkhead box O3a (FOXO3a)/p53-upregulated modulator of apoptosis (PUMA) signaling signaling.
Yang FY; Zhang L; Zheng Y; Dong H
Bioengineered; 2022 Jan; 13(1):1377-1387. PubMed ID: 34974801
[TBL] [Abstract][Full Text] [Related]
33. Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.
Liu C; Xu R
Bioengineered; 2022 May; 13(5):13300-13311. PubMed ID: 35635079
[TBL] [Abstract][Full Text] [Related]
34. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
Zhao Y; Kong GY; Pei WM; Zhou B; Zhang QQ; Pan BB
Eur Cytokine Netw; 2019 Sep; 30(3):88-97. PubMed ID: 31957703
[TBL] [Abstract][Full Text] [Related]
35. Dexmedetomidine alleviates pulmonary ischemia-reperfusion injury through modulating the miR-21-5p/Nr4a1 signaling pathway.
Dong W; Yang H; Cheng M; Zhang X; Yin J; Zeng Z; Huang G
Acta Biochim Pol; 2020 Dec; 67(4):521-529. PubMed ID: 33332077
[TBL] [Abstract][Full Text] [Related]
36. [Effects of dezocine on cardiac myocytes injury induced by hypoxia and reoxygenation in rats and its mechanism].
Wang CK; Liu XM; Tao H; Duan Y; Liu W
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Sep; 37(5):548-554. PubMed ID: 34816671
[No Abstract] [Full Text] [Related]
37. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
[TBL] [Abstract][Full Text] [Related]
38. The protective effect of lycopene on hypoxia/reoxygenation-induced endoplasmic reticulum stress in H9C2 cardiomyocytes.
Gao Y; Jia P; Shu W; Jia D
Eur J Pharmacol; 2016 Mar; 774():71-9. PubMed ID: 26845695
[TBL] [Abstract][Full Text] [Related]
39. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
Zhang J; Jiang H; Liu DH; Wang GN
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of miR-20a against hypoxia/reoxygenation treatment on cardiomyocytes cell viability and cell apoptosis by targeting TLR4 and inhibiting p38 MAPK/JNK signaling.
Gong XY; Zhang Y
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):793-800. PubMed ID: 31444671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
